Home›Companies›Biotech & Pharma›Eliaz Therapeutics

Eliaz Therapeutics Inc.

Updated Oct 29, 2026·Latest SEC filing Oct 24, 2025·Suggest an edit

About Eliaz Therapeutics

Eliaz Therapeutics is a private company based in Santa Rosa, California. It has reported $850,000 raised in one offering on Form D since October 2025. Its chief executive is Isaac Eliaz.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 28, 2025Oct 24, 2025$850,000fully sold4$212KSAFEsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Eliaz Therapeutics's Form D filed Oct 24, 2025.

IE
Isaac Eliaz
Chief Executive Officer and director
MG
Milton Goss
Executive officer

Sources

  1. SECEliaz Therapeutics Inc. filing history